Cargando…

Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis

Objective To evaluate the association of chocolate consumption with the risk of developing cardiometabolic disorders. Design Systematic review and meta-analysis of randomised controlled trials and observational studies. Data sources Medline, Embase, Cochrane Library, PubMed, CINAHL, IPA, Web of Scie...

Descripción completa

Detalles Bibliográficos
Autores principales: Buitrago-Lopez, Adriana, Sanderson, Jean, Johnson, Laura, Warnakula, Samantha, Wood, Angela, Di Angelantonio, Emanuele, Franco, Oscar H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163382/
https://www.ncbi.nlm.nih.gov/pubmed/21875885
http://dx.doi.org/10.1136/bmj.d4488
_version_ 1782210942265720832
author Buitrago-Lopez, Adriana
Sanderson, Jean
Johnson, Laura
Warnakula, Samantha
Wood, Angela
Di Angelantonio, Emanuele
Franco, Oscar H
author_facet Buitrago-Lopez, Adriana
Sanderson, Jean
Johnson, Laura
Warnakula, Samantha
Wood, Angela
Di Angelantonio, Emanuele
Franco, Oscar H
author_sort Buitrago-Lopez, Adriana
collection PubMed
description Objective To evaluate the association of chocolate consumption with the risk of developing cardiometabolic disorders. Design Systematic review and meta-analysis of randomised controlled trials and observational studies. Data sources Medline, Embase, Cochrane Library, PubMed, CINAHL, IPA, Web of Science, Scopus, Pascal, reference lists of relevant studies to October 2010, and email contact with authors. Study selection Randomised trials and cohort, case-control, and cross sectional studies carried out in human adults, in which the association between chocolate consumption and the risk of outcomes related to cardiometabolic disorders were reported. Data extraction Data were extracted by two independent investigators, and a consensus was reached with the involvement of a third. The primary outcome was cardiometabolic disorders, including cardiovascular disease (coronary heart disease and stroke), diabetes, and metabolic syndrome. A meta-analysis assessed the risk of developing cardiometabolic disorders by comparing the highest and lowest level of chocolate consumption. Results From 4576 references seven studies met the inclusion criteria (including 114 009 participants). None of the studies was a randomised trial, six were cohort studies, and one a cross sectional study. Large variation was observed between these seven studies for measurement of chocolate consumption, methods, and outcomes evaluated. Five of the seven studies reported a beneficial association between higher levels of chocolate consumption and the risk of cardiometabolic disorders. The highest levels of chocolate consumption were associated with a 37% reduction in cardiovascular disease (relative risk 0.63 (95% confidence interval 0.44 to 0.90)) and a 29% reduction in stroke compared with the lowest levels. Conclusions Based on observational evidence, levels of chocolate consumption seem to be associated with a substantial reduction in the risk of cardiometabolic disorders. Further experimental studies are required to confirm a potentially beneficial effect of chocolate consumption.
format Online
Article
Text
id pubmed-3163382
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-31633822011-09-08 Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis Buitrago-Lopez, Adriana Sanderson, Jean Johnson, Laura Warnakula, Samantha Wood, Angela Di Angelantonio, Emanuele Franco, Oscar H BMJ Research Objective To evaluate the association of chocolate consumption with the risk of developing cardiometabolic disorders. Design Systematic review and meta-analysis of randomised controlled trials and observational studies. Data sources Medline, Embase, Cochrane Library, PubMed, CINAHL, IPA, Web of Science, Scopus, Pascal, reference lists of relevant studies to October 2010, and email contact with authors. Study selection Randomised trials and cohort, case-control, and cross sectional studies carried out in human adults, in which the association between chocolate consumption and the risk of outcomes related to cardiometabolic disorders were reported. Data extraction Data were extracted by two independent investigators, and a consensus was reached with the involvement of a third. The primary outcome was cardiometabolic disorders, including cardiovascular disease (coronary heart disease and stroke), diabetes, and metabolic syndrome. A meta-analysis assessed the risk of developing cardiometabolic disorders by comparing the highest and lowest level of chocolate consumption. Results From 4576 references seven studies met the inclusion criteria (including 114 009 participants). None of the studies was a randomised trial, six were cohort studies, and one a cross sectional study. Large variation was observed between these seven studies for measurement of chocolate consumption, methods, and outcomes evaluated. Five of the seven studies reported a beneficial association between higher levels of chocolate consumption and the risk of cardiometabolic disorders. The highest levels of chocolate consumption were associated with a 37% reduction in cardiovascular disease (relative risk 0.63 (95% confidence interval 0.44 to 0.90)) and a 29% reduction in stroke compared with the lowest levels. Conclusions Based on observational evidence, levels of chocolate consumption seem to be associated with a substantial reduction in the risk of cardiometabolic disorders. Further experimental studies are required to confirm a potentially beneficial effect of chocolate consumption. BMJ Publishing Group Ltd. 2011-08-29 /pmc/articles/PMC3163382/ /pubmed/21875885 http://dx.doi.org/10.1136/bmj.d4488 Text en © Buitrago-Lopez et al 2011 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research
Buitrago-Lopez, Adriana
Sanderson, Jean
Johnson, Laura
Warnakula, Samantha
Wood, Angela
Di Angelantonio, Emanuele
Franco, Oscar H
Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
title Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
title_full Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
title_fullStr Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
title_full_unstemmed Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
title_short Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
title_sort chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163382/
https://www.ncbi.nlm.nih.gov/pubmed/21875885
http://dx.doi.org/10.1136/bmj.d4488
work_keys_str_mv AT buitragolopezadriana chocolateconsumptionandcardiometabolicdisorderssystematicreviewandmetaanalysis
AT sandersonjean chocolateconsumptionandcardiometabolicdisorderssystematicreviewandmetaanalysis
AT johnsonlaura chocolateconsumptionandcardiometabolicdisorderssystematicreviewandmetaanalysis
AT warnakulasamantha chocolateconsumptionandcardiometabolicdisorderssystematicreviewandmetaanalysis
AT woodangela chocolateconsumptionandcardiometabolicdisorderssystematicreviewandmetaanalysis
AT diangelantonioemanuele chocolateconsumptionandcardiometabolicdisorderssystematicreviewandmetaanalysis
AT francooscarh chocolateconsumptionandcardiometabolicdisorderssystematicreviewandmetaanalysis